These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 16806915)

  • 1. Development of first photoresponsive prodrug of paclitaxel.
    Skwarczynski M; Noguchi M; Hirota S; Sohma Y; Kimura T; Hayashi Y; Kiso Y
    Bioorg Med Chem Lett; 2006 Sep; 16(17):4492-6. PubMed ID: 16806915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of novel water-soluble photocleavable protective group and its application for design of photoresponsive paclitaxel prodrugs.
    Noguchi M; Skwarczynski M; Prakash H; Hirota S; Kimura T; Hayashi Y; Kiso Y
    Bioorg Med Chem; 2008 May; 16(10):5389-97. PubMed ID: 18440235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel approach of water-soluble paclitaxel prodrug with no auxiliary and no byproduct: design and synthesis of isotaxel.
    Hayashi Y; Skwarczynski M; Hamada Y; Sohma Y; Kimura T; Kiso Y
    J Med Chem; 2003 Aug; 46(18):3782-4. PubMed ID: 12930140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. O-N intramolecular acyl migration reaction in the development of prodrugs and the synthesis of difficult sequence-containing bioactive peptides.
    Sohma Y; Hayashi Y; Skwarczynski M; Hamada Y; Sasaki M; Kimura T; Kiso Y
    Biopolymers; 2004; 76(4):344-56. PubMed ID: 15386265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulating paclitaxel bioavailability for targeting prostate cancer.
    Kumar SK; Williams SA; Isaacs JT; Denmeade SR; Khan SR
    Bioorg Med Chem; 2007 Jul; 15(14):4973-84. PubMed ID: 17502149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No auxiliary, no byproduct strategy for water-soluble prodrugs of taxoids: scope and limitation of O-N intramolecular acyl and acyloxy migration reactions.
    Skwarczynski M; Sohma Y; Noguchi M; Kimura M; Hayashi Y; Hamada Y; Kimura T; Kiso Y
    J Med Chem; 2005 Apr; 48(7):2655-66. PubMed ID: 15801856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New Taxol (paclitaxel) prodrugs designed for ADEPT and PMT strategies in cancer chemotherapy.
    Alaoui AE; Saha N; Schmidt F; Monneret C; Florent JC
    Bioorg Med Chem; 2006 Jul; 14(14):5012-9. PubMed ID: 16554162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new paclitaxel prodrug for use in ADEPT strategy.
    Bouvier E; Thirot S; Schmidt F; Monneret C
    Org Biomol Chem; 2003 Oct; 1(19):3343-52. PubMed ID: 14584798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and characterization of a photoresponsive doxorubicin/combretastatin A4 hybrid prodrug.
    Liu W; Liang L; Zhao L; Tan H; Wu J; Qin Q; Gou X; Sun X
    Bioorg Med Chem Lett; 2019 Feb; 29(3):487-490. PubMed ID: 30553736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Squalenoyl prodrug of paclitaxel: synthesis and evaluation of its incorporation in phospholipid bilayers.
    Sarpietro MG; Ottimo S; Paolino D; Ferrero A; Dosio F; Castelli F
    Int J Pharm; 2012 Oct; 436(1-2):135-40. PubMed ID: 22728161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the delivery of glycan-based paclitaxel prodrugs to cancer cells via glucose transporters.
    Lin YS; Tungpradit R; Sinchaikul S; An FM; Liu DZ; Phutrakul S; Chen ST
    J Med Chem; 2008 Dec; 51(23):7428-41. PubMed ID: 19053781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Site-specific prodrug release using visible light.
    Jiang MY; Dolphin D
    J Am Chem Soc; 2008 Apr; 130(13):4236-7. PubMed ID: 18335942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of substitution patterns on the release rates of opioid peptides DADLE and [Leu(5)]-enkephalin from coumarin prodrug moieties.
    Zych LA; Yang W; Liao Y; Griffin KR; Wang B
    Bioorg Chem; 2004 Apr; 32(2):109-23. PubMed ID: 14990309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and biological evaluation of 2'-carbamate-linked and 2'-carbonate-linked prodrugs of paclitaxel: selective activation by the tumor-associated protease plasmin.
    de Groot FM; van Berkom LW; Scheeren HW
    J Med Chem; 2000 Aug; 43(16):3093-102. PubMed ID: 10956217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of the O-N intramolecular acyl migration reaction in medicinal chemistry.
    Skwarczynski M; Kiso Y
    Curr Med Chem; 2007; 14(26):2813-23. PubMed ID: 18045127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel photoresponsive cross-linking oligodeoxyribonucleotides having a caged α-chloroaldehyde.
    Kobori A; Yamauchi T; Nagae Y; Yamayoshi A; Murakami A
    Bioorg Med Chem; 2012 Sep; 20(17):5071-6. PubMed ID: 22871262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, and bioavailability evaluation of coumarin-based prodrug of meptazinol.
    Xie Q; Wang X; Wang X; Jiang Z; Qiu Z
    Bioorg Med Chem Lett; 2005 Nov; 15(22):4953-6. PubMed ID: 16154745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulating the therapeutic activity of nanoparticle delivered paclitaxel by manipulating the hydrophobicity of prodrug conjugates.
    Ansell SM; Johnstone SA; Tardi PG; Lo L; Xie S; Shu Y; Harasym TO; Harasym NL; Williams L; Bermudes D; Liboiron BD; Saad W; Prud'homme RK; Mayer LD
    J Med Chem; 2008 Jun; 51(11):3288-96. PubMed ID: 18465845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and characterization of water-soluble prodrug, liposomes and micelles of Paclitaxel.
    Dhanikula AB; Panchagnula R
    Curr Drug Deliv; 2005 Jan; 2(1):75-91. PubMed ID: 16305410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paclitaxel prodrugs: toward smarter delivery of anticancer agents.
    Skwarczynski M; Hayashi Y; Kiso Y
    J Med Chem; 2006 Dec; 49(25):7253-69. PubMed ID: 17149855
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.